Validity, reliability and prevalence of four 'clinical content' subtypes of depression

Behavioural Brain Research

Volumn 259, Issue , 2014, Pages 9-15

  Sharpley, Christopher F ^a   Bitsika, Vicki ^b  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b BOND UNIVERSITY   (Australia)

Author keywords

Assessment; Clinical; Depression; Diagnosis; Reliability; Validity

Indexed keywords

ARTICLE; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CONTENT ANALYSIS; CONTENT VALIDITY; CRITERION RELATED VALIDITY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PERSONALIZED MEDICINE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOMETRY; RELIABILITY; SYMPTOM ASSESSMENT; TREATMENT PLANNING; ZUNG SELF RATING DEPRESSION SCALE;

ASSESSMENT; CLINICAL; DEPRESSION; DIAGNOSIS; RELIABILITY; VALIDITY;

DEPRESSION; FEMALE; HUMANS; MALE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84887539788     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.10.032     Document Type: Article

References (66)

1. Druss B.G., Rosenheck R.A. Patterns of health care costs associated with depression and substance abuse in a national sample. Psychiatric Services 1999, 50:214-218.
2. Judd L., Paulus M., Wells K., Rapaport M. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. American Journal of Psychiatry 1996, 163:1411-1417.
3. Nutt D. Anxiety and depression: Individual entiteis or two sides of the same coin?. International Journal of Psychiatry in Clinical Practice 2004, 8:19-24.
4. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B. Depression, chronic diseases, and decrements in health; results from the World Health Surveys. Lancet 2007, 370:851-858.
5. Langa K.M., Valenstein M.A., Fendrick A.M., Kabeto M.U., Vijan S. Extent cost of informal caregiving for older Americans with symptoms of depression. American Journal of Psychiatry 2004, 161:857-863.
6. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., Murray C.J.L. Global burden of depressive disorders in the year 2000. British Journal of Psychiatry 2004, 184:386-392.
7. Vos T., Flaxman A., Naghavi M., Lozano R., Michaud C., Ezzati M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
8. Mykletun A., Bjerkeset O., Øverland S., Prince M., Dewey M., Stewart R. Levels of anxiety and depression as predictors of mortality: the HUNT study. British Journal of Psychiatry 2009, 195:118-125.
9. Halbreich U. Major depression is not a diagnosis, it is a departure point to diferential diagnosis-clinical and hormonal considerations. Psychoneuroendocrinology 2006, 31:16-22.
10. Baumeister H., Parker G. Meta-review of depressive subtyping models. Journal of Affective Disorders 2012, 139:126-140.
11. Ghaemi S., Vohringer P. The heterogeneity of depression: an old debate renewed. Acta Psychiatrica Scandinavia 2011, 124:497.
12. Luyten P., Blatt S., van Houdenhove B., Corveleyn J. Depression research and treatment: asre we skating to where the puck is going to be?. Clinical Psychology Review 2006, 26:985-999.
13. Parker G. Beyond major depression. Psychological Medicine 2005, 41:467-474.
14. Ostergaard S., Jensen S., Bech P. The heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatrica Scandinavia 2011, 124:495-496.
15. Antonijevic I. Depressive disorders-is it time to endorse different pathophysiologies?. Psychoneuroendocrinology 2006, 31:1-15.
16. Karasz A. The development of valid subtypes for depression in primary care settings. Journal of Nervous and Mental Disorders. 2008, 196:289-296.
17. Insel T. Transforming diagnosis 2013, National Institute of Mental Health, USA, Post.
18. Mahli G., Hitching R., Coulston C., Boyce P., Porter R., Fritz K. Individualized management of unipolar depression. Acta Psychiatrica Scandinavia 2013, 127:1-5.
19. Chou K., Yu K. Atypical depressive symptoms and obesity in a national sample of older adults with major depressive disorder. Depression and Anxiety 2013.
20. Simon G., Perlis R. Personalized medicine for depression: can we match patients with treatments?. American Journal of Psychiatry 2010, 167:1445-1455.
21. Sharpley C., Bitsika V. Differences in neurobiological pathways of four "clinical content" subtypes of depression. Behavioural Brain Research 2013, 256:368-376.
22. Korszun A., Moskvina V., Brewster S., Craddock N., Ferrero F., Gill M., et al. Familiality of symptom dimensions in depression. Archives of General Psychiatry 2004, 61:468-474.
23. Kendler K.S., Aggen S.H., Neale M.C. Evidence of multiple genetic factors underlying DSM-IV criteria for major depression. JAMA Psychiatry 2013.
24. Tabachnick B., Fidell L. Using multivariate statistics 2007, Pearson, NY. 5th ed.
25. Mitchell A., Vaze A., Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009, 374:609-619.
26. Beck A., Ward C., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4.
27. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960, 23:56-62.
28. Zigmond A., Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavia 1983, 67:361-370.
29. Derogatis L., Lipman R., Covi L. SCL-90: An outpatient psychiatric rating scale-preliminary report. Psychopharmacology Bulletin 1973, 9:13-28.
30. Zung W. A self-rating depression scale. Archives of General Psychiatry 1965, 12:63-70.
31. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
32. Geisser M., Roth R., Robinson M. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clinical Journal of Pain 1997, 13:163-170.
33. Zung W. A rating instrument for anxiety disorders. Psychosomatics 1971, 12:371-379.
34. Zung W. How normal is anxiety? 1980, Upjohn, Durham, NC.
35. Fountoulakis K.N., Bech P., Panagiotidis P., Siamouli M., Kantartzis S., Papadopoulou A., et al. Comparison of depressive indices: reliability, validity, relationship to anxiety and personality and the role of age and life events. Journal of Affective Disorders 2007, 97:187-195.
36. Spitzer R., Kroenke K., Williams J. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Journal of the American Medical Association 1999, 282:1737-1744. Group. atPHQPCS.
37. WHO Well bring measures in primary health care: the DepCare Project. Europe ROf 1998, WHO, Copenhagen. World Health Organisation (Ed.).
38. Bech P. Quality of life instruments in depression. European Psychiatry 1997, 12:194-198.
39. Bech P., Rasmussen N.A., Olsen L.R., Noerholm V., Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. Journal of Affective Disorders 2001, 66:159-164.
40. Olsen L., Jensen D., Noerholm V., Martiny K., Bech P. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychological Medicine 2003, 33:351-356.
41. Aben I., Verhey F., Lousberg R., Lodder J., Honig A. Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton Depression Rating Scale as Screening Instruments for Depression in Stroke Patients. Psychosomatics 2002, 43:386-393.
42. Löwe B., Spitzer R.L., Gräfe K., Kroenke K., Quenter A., Zipfel S., et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. Journal of Affective Disorders 2004, 78:131-140.
43. Lowe B., Spitzer R., Grafe K., Kroenke K., Quenter A., Zipfel S., et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. Journal of Affective Disorders 2004, 78:131-140.
44. DeJonge J., Baneke J. The Zung self-rating depression scale: a replication study on reliability, validity and prediction. Psychological Reports 1989, 64:833-834.
45. Gabrys J., Peters K. Reliability, discriminant and predictive validity of the Zung self-rating depression scale. Psychological Reports 1985, 57:1091-1096.
46. Schaefer A., Brown J., Watson C., Plenel D., DeMotts J., Howard M., et al. Comparison of the validities of the Beck, Zung and MMPI depression scales. Journal of Consulting and Clinical Psychology 1985, 53:415-418.
47. Agrell B., Dehlin O. Comparison of six depression scales in geriatric stroke patients. Stroke 1989, 20:1190-1194.
48. Zung W. From art to science: the diagnosis and treatment of depression. Archives of General Psychiatry 1973, 29:328-337.
49. APA Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed. (Text Revision).
50. Bitsika V., Sharpley C., Peters K. How is resilience associated with anxiety and depression? Analysis of factor score interactions within a homogenous sample. German Journal of Psychiatry 2010, 13:9-16.
51. Sharpley C., Bitsika V., Christie D. Understanding the causes of depression among prostate cancer patients: development of the effects of prostate cancer on lifestyle questionnaire. Psycho-Oncology 2009, 18:162-168.
52. Sharpley C., Bitsika V., Christie D. "Why I feel bad": refinement of the effects of prostate cancer upon lifestyle questionnaire and an initial exploration of its links with anxiety and depression among prostate cancer patients. Psycho-Oncology 2010, 19:839-846.
53. Sharpley C., Bitsika V., Christie D. The role of melancholia in prostate cancer patients' depression. BMC Psychiatry 2011, 11:201.
54. Sharpley C., Christie D. 'How I was then and how I am now': current and retrospective self-reports of anxiety and depression in Australian women with breast cancer. Psycho-Oncology 2007, 16:752-762.
55. Sharpley C., Bitsika V., Christie D. Understanding the functionality of depression among Australian breast cancer patients: implications for cognitive and behavioral interventions. International Journal of Behavioral Medicine 2010, 18:319-324.
56. Raison C., Miller A. Depression in cancer: new developments regarding diagnosis and treatment. Biological Psychiatry 2003, 54:283-294.
57. Mirescu C., Gould E. Stress and adult neurogenesis. Hippocampus 2006, 16:233-238.
58. Schmidtt N. Uses and abuses of coefficient alpha. Psychological Assessment 1996, 8:350-353.
59. Green S., Lissitz R., Mulaik S. Limitations of coefficient alpha as an index of test unidimensionality. Educational and Psychological Measurement 1977, 37:827-838.
60. Cortina J. What is coefficient alpha? An examination of theory and applications. Journal of Applied Psychology 1993, 78:98-104.
61. Briggs S., Cheek J. The role of factor analysis in the development and evaluation of personality scales. Journal of Personality 1986, 54:106-148.
62. Sharpley C., Bitsika V., Christie D. Do patient-reported androgen-deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial interventions. Journal of Psychosocial Oncology 2012, 30:185-197.
63. Anastasi A. Psychological testing 1982, Collier Macmillan, NY. 5th ed.
64. Jackson C. The general health questionnaire. Occupational Medicine 2007, 57:79.
65. Bjellande I., Dahl A., Haug T., Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. Journal of Psychosomatic Research 2002, 52:69-77.
66. NIMH The National Institute of Mental Health Strategic Plan 2008, National Institute of Mental Health, Washington, DC.